The Combination of Cannabidiol and Δ -Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma Model: Molecular Cancer Therapeutics – December 2014 13(12)

Reports the efficacy of CBD:THC in combination with radiation in treating brain cancer using cannabis at a ratio of 1:1 of CBD and THC. The Indica strain of cannabis used for brain tumors is between 25%-35% THC. They concluded that “the triple combination of CBD, THC, and irradiation significantly inhibited tumor progression in an orthotopic syngeneic model.

The Therapeutic Potential of Cannabis and Cannabinoids: Deutsches Arzteblatt International – 2012 Jul; 109(29-30)

There is now clear evidence that cannabinoids are useful for the treatment of various medical conditions. Knowledge about the therapeutic potential of cannabis products has been greatly improved by a large number of clinical trials in recent years (1– 5). In October 2008, the German Medical Association, the National Association of Statutory Health Insurance Physicians, and the Drug Commission of the German Medical Association issued the following statement at a hearing of the Health Committee of the German Federal Parliament (Bundestag): “The benefit of treatment with cannabinoids for a number of medical indications has been shown in controlled trials in which predominantly standardized and/or synthetic cannabinoid preparations were used. The use of such preparations may therefore be reasonable for patients in whom conventional treatment does not achieve adequate relief of symptoms such as spasticity, pain, nausea, vomiting, or loss of appetite” (6). The first cannabis-based medication was approved for use in Germany in 2011. In this article we present the current state of knowledge on the therapeutic application of cannabinoid medications.

A Hidden Origin Story of the CBD Craze: New York Times – May 23, 2020

The history of discovering that THC is vital to the effectiveness of CBD. This explains why some cannabis studies find ineffectiveness. To be accurate research must measure CBD:THC dosage. “Within a couple of years, they figured out a 1:1 combination of a high-THC chemovar and a high-CBD chemovar presented the greatest latitude of effects and prevention of side effects,” said Dr. Ethan Russo, who worked with GW Pharmaceuticals from 1998 to 2014.